39118068|t|IL-1beta-activated PI3K/AKT and MEK/ERK pathways coordinately promote induction of partial epithelial-mesenchymal transition.
39118068|a|Epithelial-mesenchymal transition (EMT) is a cellular process in embryonic development, wound healing, organ fibrosis, and cancer metastasis. Previously, we and others have reported that proinflammatory cytokine interleukin-1beta (IL-1beta) induces EMT. However, the exact mechanisms, especially the signal transduction pathways, underlying IL-1beta-mediated EMT are not yet completely understood. Here, we found that IL-1beta stimulation leads to the partial EMT-like phenotype in human lung epithelial A549 cells, including the gain of mesenchymal marker (vimentin) and high migratory potential, without the complete loss of epithelial marker (E-cadherin). IL-1beta-mediated partial EMT induction was repressed by PI3K inhibitor LY294002, indicating that the PI3K/AKT pathway plays a significant role in the induction. In addition, ERK1/2 inhibitor FR180204 markedly inhibited the IL-1beta-mediated partial EMT induction, demonstrating that the MEK/ERK pathway was also involved in the induction. Furthermore, we found that the activation of the PI3K/AKT and MEK/ERK pathways occurred downstream of the epidermal growth factor receptor (EGFR) pathway and the IL-1 receptor (IL-1R) pathway, respectively. Our findings suggest that the PI3K/AKT and MEK/ERK pathways coordinately promote the IL-1beta-mediated partial EMT induction. The inhibition of not one but both pathways is expected yield clinical benefits by preventing partial EMT-related disorders such as organ fibrosis and cancer metastasis.
39118068	0	8	IL-1beta	Gene	3553
39118068	19	23	PI3K	Gene	5293
39118068	24	27	AKT	Gene	207
39118068	32	35	MEK	Gene	5609
39118068	36	39	ERK	Gene	5594
39118068	235	243	fibrosis	Disease	MESH:D005355
39118068	249	266	cancer metastasis	Disease	MESH:D009369
39118068	338	355	interleukin-1beta	Gene	3553
39118068	357	365	IL-1beta	Gene	3553
39118068	467	475	IL-1beta	Gene	3553
39118068	544	552	IL-1beta	Gene	3553
39118068	608	613	human	Species	9606
39118068	630	634	A549	CellLine	CVCL:0023
39118068	684	692	vimentin	Gene	7431
39118068	772	782	E-cadherin	Gene	999
39118068	785	793	IL-1beta	Gene	3553
39118068	842	846	PI3K	Gene	5293
39118068	857	865	LY294002	Chemical	MESH:C085911
39118068	887	891	PI3K	Gene	5293
39118068	892	895	AKT	Gene	207
39118068	977	985	FR180204	Chemical	MESH:C505241
39118068	1009	1017	IL-1beta	Gene	3553
39118068	1073	1076	MEK	Gene	5609
39118068	1077	1080	ERK	Gene	5594
39118068	1174	1178	PI3K	Gene	5293
39118068	1179	1182	AKT	Gene	207
39118068	1187	1190	MEK	Gene	5609
39118068	1191	1194	ERK	Gene	5594
39118068	1231	1263	epidermal growth factor receptor	Gene	1956
39118068	1265	1269	EGFR	Gene	1956
39118068	1287	1300	IL-1 receptor	Gene	3554
39118068	1302	1307	IL-1R	Gene	3554
39118068	1362	1366	PI3K	Gene	5293
39118068	1367	1370	AKT	Gene	207
39118068	1375	1378	MEK	Gene	5609
39118068	1379	1382	ERK	Gene	5594
39118068	1417	1425	IL-1beta	Gene	3553
39118068	1596	1604	fibrosis	Disease	MESH:D005355
39118068	1609	1626	cancer metastasis	Disease	MESH:D009369
39118068	Negative_Correlation	MESH:C085911	5293
39118068	Association	207	3553
39118068	Negative_Correlation	MESH:C085911	3553
39118068	Negative_Correlation	MESH:C505241	3553
39118068	Association	3554	5609
39118068	Association	1956	5594
39118068	Positive_Correlation	3553	5293
39118068	Association	3553	5609
39118068	Association	1956	5609
39118068	Association	1956	207
39118068	Association	207	3554
39118068	Association	1956	5293
39118068	Positive_Correlation	3553	7431
39118068	Association	3554	5594
39118068	Association	5594	5609
39118068	Association	207	5293
39118068	Association	3553	5594
39118068	Association	3554	5293

